Patent details

EP2897981 Title: ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF

Basic Information

Publication number:
EP2897981
PCT Application Number:
US2013060511
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137734760
PCT Publication Number:
WO2014047231
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-CD3 ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND CD3 AND CD20, AND USES THEREOF
French Title of Invention:
ANTICORPS ANTI-CD3, MOLÉCULES DE LIAISON À UN ANTIGÈNE BISPÉCIFIQUES QUI SE LIENT À CD3 ET CD20, ET LEURS UTILISATIONS
German Title of Invention:
ANTI-CD3-ANTIKÖRPER, BISPEZIFISCHE ANTIGENBINDENDE MOLEKÜLE ZUR BINDUNG VON CD3 UND CD20 SOWIE VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
19/09/2013
Grant date:
07/06/2023
EP Publication Date:
29/07/2015
PCT Publication Date:
27/03/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2023
EP B1 Publication Date:
07/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/09/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2023
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
08/06/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PAPADOPOULOS, Nicholas, J.
Address:
United States (US)

2

Name:
SMITH, Eric
Address:
United States (US)

Priority

1

Priority Number:
201261704029 P
Priority Date:
21/09/2012
Priority Country:
United States (US)

2

Priority Number:
201361753461 P
Priority Date:
17/01/2013
Priority Country:
United States (US)

3

Priority Number:
201361763110 P
Priority Date:
11/02/2013
Priority Country:
United States (US)

4

Priority Number:
201361827098 P
Priority Date:
24/05/2013
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; A61K 39/00; A61K 39/395; A61P 35/00; A61P 35/02; A61P 37/04;

Publication

European Patent Bulletin

Issue number:
202323
Publication date:
07/06/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
20/08/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
08/06/2023 Power Of Attorney 1
09/06/2023 Outgoing Correspondence 1